Eudaimonia Partners, LLC Eli Lilly & CO Transaction History

Eudaimonia Partners, LLC

$416 Million
Q1 2024

A detailed history of Eudaimonia Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Eudaimonia Partners, LLC holds 726 shares of LLY stock, worth $543,055. This represents 0.14% of its overall portfolio holdings.

Number of Shares

726

Previous 784 7.4%

Holding current value

$543,055

Previous $457,000 23.41%

% of portfolio

0.14%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $34,347 - $45,952	-58 Reduced 7.4%	726 $564,000
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $606,069 - $714,476	-1,154 Reduced 59.55%	784 $457,000
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $38,688 - $53,337	-89 Reduced 4.39%	1,938 $1.04 Million
Q2 2023 Jul 19, 2023	BUY	$350.74 - $468.98 $12,977 - $17,352	37 Added 1.86%	2,027 $950,000
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $46,905 - $55,087	-151 Reduced 7.05%	1,990 $683,000
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $18,328 - $21,356	57 Added 2.74%	2,141 $0
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $603,040 - $687,227	-2,034 Reduced 49.39%	2,084 $674,000
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $78,323 - $91,962	-281 Reduced 6.39%	4,118 $1.34 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $193,149 - $240,036	823 Added 23.01%	4,399 $1.26 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $443 - $545	-2 Reduced 0.06%	3,576 $826,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $13,902 - $17,982	-77 Reduced 2.11%	3,578 $821,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1,150 - $1,489	7 Added 0.19%	3,655 $683,000
Q4 2020 Feb 18, 2021	SELL	$130.46 - $172.63 $5,740 - $7,595	-44 Reduced 1.19%	3,648 $616,000
Q3 2020 Nov 23, 2020	BUY	$146.22 - $169.13 $539,844 - $624,427	3,692 New	3,692 $546,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $426,962 - $493,859	-2,920 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 3.31%	2,920 $479,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $52,739 - $65,276	-443 Reduced 12.79%	3,020 $419,000
Q4 2019 May 05, 2020	BUY	$106.92 - $132.43 $370,263 - $458,605	3,463 New	3,463 $455,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.

Account

Eudaimonia Partners, LLC Eli Lilly & CO Transaction History